Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Aventis Pharma S.A. et al v. Sandoz Inc.
Case Number:
1:11-cv-00043
Court:
Nature of Suit:
Judge:
Firms
Sectors & Industries:
-
March 11, 2011
Aventis, Sandoz Drop Swords In Taxotere Patent Suit
Aventis Pharma SA and Sanofi-Aventis U.S. LLC decided Friday to stop fighting a judgment in favor of Sandoz Inc. in its patent suit over Sandoz's generic version of cancer treatment Taxotere.
-
February 02, 2011
Australian Judge Allows Sale Of Generic Taxotere
A judge in Australia has ruled that two generic-drug makers can sell a copy of blockbuster cancer-fighting drug Taxotere when a patent for it expires, denying a bid by Sanofi-Aventis SA to block the generic version.